890 studies found for:    Open Studies | "Prostatic Diseases"
Show Display Options
Rank Status Study
21 Recruiting Transrectal MRI-Guided Biopsy in Identifying Cancer in Patients With Suspected Prostate Cancer
Conditions: Health Status Unknown;   Prostate Carcinoma
Interventions: Procedure: 3 Tesla Magnetic Resonance Imaging;   Radiation: Gadodiamide;   Procedure: Multiparametric Magnetic Resonance Imaging;   Procedure: Transrectal Biopsy;   Procedure: Ultrasound-Guided Prostate Biopsy
22 Not yet recruiting Enzalutamide and Niraparib in the Treatment of Metastatic Castrate-Resistant Prostate Cancer (CRPC)
Condition: Metastatic Prostate Cancer
Interventions: Drug: Enzalutamide;   Drug: Niraparib
23 Recruiting Evaluate, Safety and Tolerability of Intraprostatic PRX302 Administration, Low to Intermediate Risk Prostate Cancer
Condition: Prostate Cancer
Intervention: Drug: PRX302
24 Recruiting Vaccine Therapy and Pembrolizumab in Treating Patients With Hormone-Resistant, Metastatic Prostate Cancer
Conditions: Hormone-Resistant Prostate Cancer;   Metastatic Malignant Neoplasm in the Bone;   Metastatic Malignant Neoplasm in the Soft Tissues;   Metastatic Prostate Carcinoma;   Prostate Adenocarcinoma;   Recurrent Prostate Carcinoma;   Stage IV Prostate Cancer
Interventions: Biological: Pembrolizumab;   Biological: pTVG-HP Plasmid DNA Vaccine
25 Not yet recruiting A Selective Androgen Receptor Modulator for Symptom Management in Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: LY2452473;   Drug: Placebo
26 Not yet recruiting Aqueduct Irrigation System Clinical Protocol: Medical Device Investigational Plan
Conditions: Prostatic Hyperplasia;   Kidney Calculi;   Bladder Tumors
Intervention: Device: Aqueduct
27 Not yet recruiting European Observational Study of Enzalutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC)
Condition: Metastatic Castration Resistant Prostate Cancer
Intervention: Drug: enzalutamide
28 Not yet recruiting LEE011 (Ribociclib) in Combination With Docetaxel Plus Prednisone in mCRPC
Condition: Prostate Cancer
Interventions: Drug: Docetaxel;   Drug: Ribociclib;   Drug: Prednisone;   Drug: Filgrastim
29 Not yet recruiting Hormonal Therapy and Chemotherapy Followed by Prostatectomy in Patients With Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: Degarelix;   Drug: Doxorubicin;   Drug: Ketoconazole;   Drug: Docetaxel;   Drug: Estramustine
30 Not yet recruiting The PK Characteristics of the JLP-1207(Solifenacin/Tamsulosin 5mg/0.2mg) and Co-administration of Solifenacin and Tamsulosin in Healthy Male Volunteers.
Conditions: LUTS(Lower Urinary Tract Symptoms);   Benign Prostatic Hyperplasia;   Overactive Bladder
Interventions: Drug: JLP-1207;   Drug: Solifenacin 5mg + Tamsulosin 0.2mg
31 Not yet recruiting Dexamethasone Prior to Re-treatment With Enzalutamide in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Previously Treated With Enzalutamide and Docetaxel
Conditions: Prostate Cancer;   Metastatic Prostate Carcinoma;   Prostate Adenocarcinoma;   Stage IV Prostate Cancer
Interventions: Drug: Dexamethasone;   Drug: Enzalutamide;   Other: Laboratory Biomarker Analysis;   Other: Quality-of-Life Assessment
32 Not yet recruiting Pembrolizumab and Cryosurgery in Treating Patients With Newly Diagnosed, Oligo-metastatic Prostate Cancer
Condition: Stage IV Prostate Cancer
Interventions: Procedure: Cryosurgery;   Drug: Degarelix;   Other: Laboratory Biomarker Analysis;   Biological: Pembrolizumab
33 Not yet recruiting A Study of JNJ-56021927 Plus Androgen Deprivation Therapy (ADT) Versus ADT in Participants With Low-Volume mHSPC
Condition: Prostate Cancer
Interventions: Drug: JNJ-56021927;   Drug: Placebo;   Drug: Androgen Deprivation Therapy (ADT)
34 Not yet recruiting Improving Prostate Cancer Detection Using MRI-Targeted TRUS-Guided Biopsy
Condition: Prostate Cancer
Interventions: Device: TRUS-Guided Biopsy;   Device: MRI + TRUS-Guided Biopsy
35 Recruiting 68Ga-PSMA PET/CT or PET/MRI in Evaluating Patients With Recurrent Prostate Cancer
Condition: Recurrent Prostate Carcinoma
Interventions: Procedure: Computed Tomography;   Radiation: Gallium Ga 68-labeled PSMA Ligand Glu-urea-Lys(Ahx);   Other: Laboratory Biomarker Analysis;   Procedure: Magnetic Resonance Imaging;   Procedure: Positron Emission Tomography
36 Recruiting Dose Finding Study of BKM 120 in Combination With LH-RH Agonists and Bicalutamide in Men With Non Castrate Metastatic Prostate Cancer
Condition: Non Castrate Metastatic Prostate Cancer
Intervention: Drug: BKM120 in combination with LH-RH agonists (suprefact) and bicalutamide
37 Not yet recruiting A Pilot Study to Assess the Immunogenicity of Candidate PSA Peptides for a Prostate Cancer Vaccine
Condition: Prostate Cancer
Intervention: Other: Blood draw
38 Not yet recruiting Cabazitaxel Versus the Switch to Alternative AR-targeted Agent (Enzalutamide or Abiraterone) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Patients Previously Treated With Docetaxel and Who Rapidly Failed a Prior AR-targeted Agent
Condition: Prostate Cancer Metastatic
Interventions: Drug: cabazitaxel XRP6258;   Drug: enzalutamide;   Drug: abiraterone acetate;   Drug: prednisone
39 Not yet recruiting Efficacy of Extracorporeal Biofeedback Device for Post-prostatectomy Incontinence
Conditions: Prostate Neoplasm;   Prostatectomy;   Surgical Procedures, Robotic;   Urinary Incontinence;   Biofeedback;   Pelvic Floor;   Exercise
Intervention: Device: Extracorporeal biofeedback device (Any Kegel)
40 Not yet recruiting Assessment of Prostate MRI Before Prostate Biopsies
Condition: Prostate Cancer
Intervention: Procedure: Prostate biopsy

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years